University Of Texas Hlth Sci Ctr Houston

  • The newly established UTHealth Institute for Implementation Science seeks a candidate who demonstrates interest and expertise in interdisciplinary implementation science. Under the supervision and mentorship of UTHealth Institute for Implementation Directors Bijal Balasubramanian, M.B.B.S, PhD & Maria E. Fernandez, PhD, the Postdoctoral Research Fellow will participate in, design, organize and

  • The Center for Clinical and Translational Sciences (CCTS) was the nation’s first multi-institutional Clinical and Translational Science Award (CTSA) program. The CCTS was funded in 2006 in the first class of CTSAs and was originally a collaboration in Houston between The University of Texas Health Science Center at Houston (UTHSC-H) and The University of Texas M. D. Anderson Cancer Center (UT
  • Performs grant program development, application, administration and reporting for the Center for Clinical and Translational Sciences. Works closely with Director, Center for Clinical and Translational Sciences (CCTS) Grant Programs and other CCTS staff on scientific and administrative aspects of the CCTS. Assists in writing grant proposals to both private foundations and governmental agencies. May
  • University Of Texas Hlth Sci Ctr Houston

    Clinical and research data are increasingly collected and aggregated in clinical data warehouses (CDWs). Access to these data is subject to local, state and national regulations. For multiple reasons, institutions differ in how they interpret and apply these regulations. Sometimes, inter-institutional differences are unavoidable, such as when regulations clearly require specific practices. However

  • University Of Texas Hlth Sci Ctr Houston

    There has been a true revolution in cancer treatment. Numerous genetic alterations are being targeted using new therapies with the potential for improved, less toxic – often durable - outcomes in advanced cancer. Response rates are 3-5% for unmatched treatment with new tyrosine kinases and other similar agents whereas a “high value” alteration can result in response rates of 30-50% for actionable

  • DSC_RDCRN
    Autism spectrum disorder (ASD) affects 1 in 59 children in the United States and is a major public health concern and challenge. The Developmental Synaptopathies Consortium (DSC) aims to explore the underlying causes of autism by focusing on three rare genetic disorders related to ASD, including Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Tumor Syndrome (PHTS) and Phelan-McDermid Syndrome
  • Texas Regional CTSA Consortium Logo

    With its Lowering the Barriers program, the Texas CTSA Consortium is facilitating collaboration among the Texas CTSAs and other interested biomedical research institutions by an IRB reciprocity agreement and sharing of resources, expertise, and patient populations. The Texas CTSAs' BERD, bioinformatics, ethics, and PCIR components are meeting regularly to exchange best practices and tackle joint

  • Learning Healthcare: An Ongoing Paradigm Shift
    University Of Texas Hlth Sci Ctr Houston

    Learning healthcare (LHC) incorporates learning seamlessly into everyday patient care and is crucial to rapidly advancing patient outcomes and ultimately population health. Observational studies are valuable in generating new hypotheses and identifying highly effective therapies (resulting in a published relative risk for adverse outcome <0.10 compared to placebo or usual care). However, the great

  • Image

    University of Texas Health Science Center Houston

    The goal of the Center for Clinical and Translational Sciences (CCTS) is to facilitate clinical and translational research at The University of Texas Health Science Center at Houston (UTHealth), The University of Texas M. D. Anderson Cancer Center, and the Memorial Hermann Hospital System.